CXCL12 and CXCR4 as Novel Biomarkers in Uric Acid-Induced Inflammation and Patients with Gouty Arthritis

The aim of this study was to evaluate the expression of chemokine receptor CXCR4 and its ligand CXCL12 in patients with gout and uric acid-induced inflammation. A total of 40 patients with intercritical gout and 27 controls were consecutively enrolled. The serum levels of interleukin-1β (IL-1β), IL-...

Full description

Bibliographic Details
Main Authors: Seong-Kyu Kim, Jung-Yoon Choe, Ki-Yeun Park
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/11/3/649
_version_ 1797613335795990528
author Seong-Kyu Kim
Jung-Yoon Choe
Ki-Yeun Park
author_facet Seong-Kyu Kim
Jung-Yoon Choe
Ki-Yeun Park
author_sort Seong-Kyu Kim
collection DOAJ
description The aim of this study was to evaluate the expression of chemokine receptor CXCR4 and its ligand CXCL12 in patients with gout and uric acid-induced inflammation. A total of 40 patients with intercritical gout and 27 controls were consecutively enrolled. The serum levels of interleukin-1β (IL-1β), IL-18, CXCL12, and CXCR4 were assessed using an enzyme-linked immunosorbent assay. The gene and protein expressions for these target molecules were measured in human U937 cells incubated with monosodium urate (MSU) crystals using a real-time reverse transcription polymerase chain reaction and Western blot analysis. Patients with intercritical gout showed higher serum IL-1β, IL-18, and CXCL12 levels, but not the serum CXCR4 level, than in the controls.The serum CXCR4 level in gout patients was associated with the serum IL-18 level, uric acid level, and uric acid/creatinine ratio (<i>r</i> = 0.331, <i>p</i> = 0.037; <i>r</i> = 0.346, <i>p</i> = 0.028; and <i>r</i> = 0.361, <i>p</i> = 0.022, respectively). U937 cells treated with MSU crystals significantly induced the CXCL12 and CXCR4 mRNA and protein expression in addition to IL-1β and IL-18. In cells transfected with IL-1β siRNA or IL-18 siRNA, the CXCL12 and CXCR4 expression was downregulated compared with the non-transfected cells in MSU crystal-induced inflammation. In this study, we revealed that CXCL12 and CXCR4 were involved in the pathogenesis of uric acid-induced inflammation and gouty arthritis.
first_indexed 2024-03-11T06:54:23Z
format Article
id doaj.art-457dc326a91746d0bc01b6e97e550409
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-11T06:54:23Z
publishDate 2023-02-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-457dc326a91746d0bc01b6e97e5504092023-11-17T09:43:34ZengMDPI AGBiomedicines2227-90592023-02-0111364910.3390/biomedicines11030649CXCL12 and CXCR4 as Novel Biomarkers in Uric Acid-Induced Inflammation and Patients with Gouty ArthritisSeong-Kyu Kim0Jung-Yoon Choe1Ki-Yeun Park2Division of Rheumatology, Department of Internal Medicine, Catholic University of Daegu School of Medicine, 33, Duryugongwon-ro 17-gil, Nam-gu, Daegu 42472, Republic of KoreaDivision of Rheumatology, Department of Internal Medicine, Catholic University of Daegu School of Medicine, 33, Duryugongwon-ro 17-gil, Nam-gu, Daegu 42472, Republic of KoreaArthritis and Autoimmunity Research Center, Catholic University of Daegu, 33, Duryugongwon-ro 17-gil, Nam-gu, Daegu 42472, Republic of KoreaThe aim of this study was to evaluate the expression of chemokine receptor CXCR4 and its ligand CXCL12 in patients with gout and uric acid-induced inflammation. A total of 40 patients with intercritical gout and 27 controls were consecutively enrolled. The serum levels of interleukin-1β (IL-1β), IL-18, CXCL12, and CXCR4 were assessed using an enzyme-linked immunosorbent assay. The gene and protein expressions for these target molecules were measured in human U937 cells incubated with monosodium urate (MSU) crystals using a real-time reverse transcription polymerase chain reaction and Western blot analysis. Patients with intercritical gout showed higher serum IL-1β, IL-18, and CXCL12 levels, but not the serum CXCR4 level, than in the controls.The serum CXCR4 level in gout patients was associated with the serum IL-18 level, uric acid level, and uric acid/creatinine ratio (<i>r</i> = 0.331, <i>p</i> = 0.037; <i>r</i> = 0.346, <i>p</i> = 0.028; and <i>r</i> = 0.361, <i>p</i> = 0.022, respectively). U937 cells treated with MSU crystals significantly induced the CXCL12 and CXCR4 mRNA and protein expression in addition to IL-1β and IL-18. In cells transfected with IL-1β siRNA or IL-18 siRNA, the CXCL12 and CXCR4 expression was downregulated compared with the non-transfected cells in MSU crystal-induced inflammation. In this study, we revealed that CXCL12 and CXCR4 were involved in the pathogenesis of uric acid-induced inflammation and gouty arthritis.https://www.mdpi.com/2227-9059/11/3/649goutCXCL12CXCR4uric acid
spellingShingle Seong-Kyu Kim
Jung-Yoon Choe
Ki-Yeun Park
CXCL12 and CXCR4 as Novel Biomarkers in Uric Acid-Induced Inflammation and Patients with Gouty Arthritis
Biomedicines
gout
CXCL12
CXCR4
uric acid
title CXCL12 and CXCR4 as Novel Biomarkers in Uric Acid-Induced Inflammation and Patients with Gouty Arthritis
title_full CXCL12 and CXCR4 as Novel Biomarkers in Uric Acid-Induced Inflammation and Patients with Gouty Arthritis
title_fullStr CXCL12 and CXCR4 as Novel Biomarkers in Uric Acid-Induced Inflammation and Patients with Gouty Arthritis
title_full_unstemmed CXCL12 and CXCR4 as Novel Biomarkers in Uric Acid-Induced Inflammation and Patients with Gouty Arthritis
title_short CXCL12 and CXCR4 as Novel Biomarkers in Uric Acid-Induced Inflammation and Patients with Gouty Arthritis
title_sort cxcl12 and cxcr4 as novel biomarkers in uric acid induced inflammation and patients with gouty arthritis
topic gout
CXCL12
CXCR4
uric acid
url https://www.mdpi.com/2227-9059/11/3/649
work_keys_str_mv AT seongkyukim cxcl12andcxcr4asnovelbiomarkersinuricacidinducedinflammationandpatientswithgoutyarthritis
AT jungyoonchoe cxcl12andcxcr4asnovelbiomarkersinuricacidinducedinflammationandpatientswithgoutyarthritis
AT kiyeunpark cxcl12andcxcr4asnovelbiomarkersinuricacidinducedinflammationandpatientswithgoutyarthritis